DE69524226T2 - Verfahren zum herstellen von fusidinsäuretabletten - Google Patents

Verfahren zum herstellen von fusidinsäuretabletten

Info

Publication number
DE69524226T2
DE69524226T2 DE69524226T DE69524226T DE69524226T2 DE 69524226 T2 DE69524226 T2 DE 69524226T2 DE 69524226 T DE69524226 T DE 69524226T DE 69524226 T DE69524226 T DE 69524226T DE 69524226 T2 DE69524226 T2 DE 69524226T2
Authority
DE
Germany
Prior art keywords
fusidic acid
producing
acid tablets
tablets
tabletting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69524226T
Other languages
English (en)
Other versions
DE69524226D1 (de
Inventor
Preben Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of DE69524226D1 publication Critical patent/DE69524226D1/de
Application granted granted Critical
Publication of DE69524226T2 publication Critical patent/DE69524226T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE69524226T 1994-07-26 1995-07-21 Verfahren zum herstellen von fusidinsäuretabletten Expired - Lifetime DE69524226T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9415048A GB9415048D0 (en) 1994-07-26 1994-07-26 Tablet
PCT/EP1995/002904 WO1996003128A1 (en) 1994-07-26 1995-07-21 Preparation of fusidic acid tablets

Publications (2)

Publication Number Publication Date
DE69524226D1 DE69524226D1 (de) 2002-01-10
DE69524226T2 true DE69524226T2 (de) 2002-06-27

Family

ID=10758888

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69524226T Expired - Lifetime DE69524226T2 (de) 1994-07-26 1995-07-21 Verfahren zum herstellen von fusidinsäuretabletten

Country Status (20)

Country Link
EP (1) EP0773783B1 (de)
JP (1) JP3853358B2 (de)
KR (1) KR100358614B1 (de)
CN (1) CN1070703C (de)
AT (1) ATE209496T1 (de)
AU (1) AU681980B2 (de)
CA (1) CA2193235C (de)
CZ (1) CZ286197B6 (de)
DE (1) DE69524226T2 (de)
DK (1) DK0773783T3 (de)
ES (1) ES2163521T3 (de)
FI (1) FI117666B (de)
GB (1) GB9415048D0 (de)
HU (1) HU221483B (de)
NZ (1) NZ290806A (de)
PL (1) PL180935B1 (de)
PT (1) PT773783E (de)
RO (1) RO118633B1 (de)
RU (1) RU2140272C1 (de)
WO (1) WO1996003128A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008051783A1 (de) * 2008-10-17 2010-04-22 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Valsartan enthaltende Tablette

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008659A1 (en) * 1997-08-20 1999-02-25 Fuisz Technologies Ltd. Process for improving flow and compression of tableting compositions
DK1945654T3 (en) 2005-10-31 2015-11-30 Leo Pharma As CREATING A antibiotic, CRYSTALLINE fusidic
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
JP5249568B2 (ja) * 2007-12-06 2013-07-31 旭化成ケミカルズ株式会社 成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法
EP2382968A1 (de) 2010-03-26 2011-11-02 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Partikel Groesse Verteilung von Fusidinsäure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7411402A (nl) * 1973-09-13 1975-03-17 Leo Pharm Prod Ltd Werkwijze voor het bereiden van een middel tegen arthritis.
EP0300073A1 (de) * 1987-07-22 1989-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Verwendung von Fusidinsäure zur Behandlung von dem Aids verwandten Komplexen und Aids im Endstadium

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008051783A1 (de) * 2008-10-17 2010-04-22 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Valsartan enthaltende Tablette

Also Published As

Publication number Publication date
CA2193235A1 (en) 1996-02-08
FI117666B (fi) 2007-01-15
RO118633B1 (ro) 2003-08-29
ES2163521T3 (es) 2002-02-01
CN1070703C (zh) 2001-09-12
KR970704447A (ko) 1997-09-06
PL318261A1 (en) 1997-05-26
DE69524226D1 (de) 2002-01-10
PL180935B1 (pl) 2001-05-31
HU9700217D0 (en) 1997-04-28
HU221483B (en) 2002-10-28
ATE209496T1 (de) 2001-12-15
KR100358614B1 (ko) 2003-01-10
HUT76836A (en) 1997-11-28
CZ22997A3 (en) 1997-04-16
CN1154066A (zh) 1997-07-09
AU3164495A (en) 1996-02-22
DK0773783T3 (da) 2002-04-02
FI965214A0 (fi) 1996-12-27
EP0773783B1 (de) 2001-11-28
NZ290806A (en) 1998-01-26
GB9415048D0 (en) 1994-09-14
CZ286197B6 (cs) 2000-02-16
FI965214A (fi) 1996-12-27
JPH10502937A (ja) 1998-03-17
EP0773783A1 (de) 1997-05-21
WO1996003128A1 (en) 1996-02-08
CA2193235C (en) 2008-03-18
RU2140272C1 (ru) 1999-10-27
JP3853358B2 (ja) 2006-12-06
PT773783E (pt) 2002-04-29
AU681980B2 (en) 1997-09-11

Similar Documents

Publication Publication Date Title
YU49069B (sh) Postupak za pravljenje formulacije tablete
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
ES2156997T3 (es) Proceso nuevo para la produccion de sal calcica del acido amorfo (r-(r*,r*))-2-(4-fluorofenil)-beta,delta-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)-1h-pirrol-1-heptanoico (2:1).
HRP20000142B1 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
BR0013885A (pt) Comprimidos aperfeiçoados
IS2042B (is) Aðferð til framleiðslu á efnasamsetningu til lækninga, sem er samverkandi og starfsmagnandi og aðferðir við notkun hennar
CY1674A (en) 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alcanoic acids,process for their preparation,their pharmaceutical preparation as well their therapeutic use
ATE47520T1 (de) Darmloesliche ueberzugsmasse fuer pharmazeutische verabreichungsformen.
DE58900594D1 (de) Ibuprofen-brausezubereitungen.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
IT1270239B (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
DE69524226D1 (de) Verfahren zum herstellen von fusidinsäuretabletten
ATE288271T1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
GR3018685T3 (en) Method for the manufacture of a controlled release solid unit dosage form.
AU9164291A (en) Method to produce sodium citrate using electrodialysis
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
GR1002665B (el) Μεθοδος για την περιποιηση φυτων.
HUT59316A (en) Process for producing solid, orally administrable dosage forms comprising iphosphamide as active ingredient
MA23930A1 (fr) Procede de production de granules pharmaceutiques
IE782515L (en) Treating diarrhoea
WO2001034553A3 (en) 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
CA2208611A1 (en) 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use
ECSP961662A (es) Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803